Coloplast Finance B.V. - Decisions at the Annual General Meeting
Decisions at the Annual General Meeting
On 31 January 2023, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder, Coloplast A/S approved the annual report for the financial year 2021/22 (for the first 7-months from incorporation until 30 September 2022).
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients28.3.2023 13:46:26 CEST | Press release
New AI discovery de-risking the pipeline through faster validation and has potential to enter clinical Phase 1/2a in Q4 2023Phase 2b clinical trial reduced in size and expected to reach interim data on time (Q4 2023)Increased focus extends cash runway significantly COPENHAGEN, Denmark, March 28, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the discovery and development of AI-powered immunotherapies, today announces an increased focus on its strategy around its core AI capabilities allowing fast and de-risked development of its pipeline. Recently, Evaxion announced that the Company has used its proprietary AI technology to discover a new treatment opportunity that may broaden cancer immunotherapy. Through new cancer targets, so-called ERVs (endogenous retroviruses), it may become possible to treat cancer patients who have until now been considered unresponsive to immunotherapy. This opens
Lantronix Announces New X300 Compact Cellular IoT Gateway Solution, Ideal for Mission-Critical Applications28.3.2023 13:00:00 CEST | Press release
Monitor and manage globally distributed assets with Lantronix’s X300 IoT Gateway Solution, which includes hardware, cloud-based device management, cellular connectivity, advanced security and tech support IRVINE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Industrial Internet of Things (IoT) and the Intelligent IT market, today announced its new X300 Compact Gateway IoT Solution. Ideal for secure mission-critical applications, the new X300 Cellular Compact IoT Gateway Solution combines Lantronix’s IoT gateway hardware with a premium services subscription, including centralized device management, integrated cellular data, enhanced device security and expert technical support in an all-in-one package. “At Lantronix, we are committed to providing our customers with turnkey IoT solutions that efficiently solve their connectivity and remote device management challenges while offering expert technical support
QS Ranking, Luiss University Rome rises to 14th position in the world for Politics and International Studies28.3.2023 13:00:00 CEST | Press release
Luiss joins the elite of the world's top 15 universities in Politics and International Studies in the prestigious QS World University Rankings by Subject 2023, which rewards the best institutions of higher education for individual subject areas. The University named after Guido Carli continues its ascent in this ranking, reaching the top 50 positions in the world for the "Business and Management" and "Law" areas, where it ranks 46th (2nd in Italy) and 47th respectively, climbing more than 30 positions in one year. The growing investments in research and teaching and the process of internationalization have strengthened Luiss’ status around the world. Since its first time in this prestigious ranking in 2016, Luiss has risen by over 300 positions. The QS ranking is based on indicators related to academic reputation and the reputation of its alumni as assessed by major employers. "It is a great pleasure to witness the continuous rise of Luiss towards the very top of the influential QS Int
Kapitalforeningen Blue Strait Capital – Prospektopdatering28.3.2023 12:58:54 CEST | pressemeddelelse
København K, March 28, 2023 (GLOBE NEWSWIRE) -- Opdateret prospekt for Kapitalforeningen Blue Strait Capital offentliggøres dags dato. Der er foretaget følgende opdateringer i prospektet: Tilpasning af afsnittet ”Risikoprofil” Tilpasning af afsnittet ”Risici knyttet til investors valg af afdeling”Tilpasning af afsnittet ”Risikoskala og risikoprofil”Justering af teksten under afsnittet ”Politiske forhold”Tilpasning af afsnittet ”Værdi- og prisfastsættelse af aktiver” Prospektet er vedhæftet denne fondsbørsmeddelelse og kan endvidere downloades på www.bluestraitcapital.dk, eller rekvireres ved henvendelse til BI Management A/S, Bredgade 40, 1260 København K, tlf. 77 30 90 00. Henvendelser vedrørende denne meddelelse kan rettes til direktør Martin Fjordlund Smidt på tlf. 77 30 90 00. Med venlig hilsen BI Management A/S Martin Fjordlund Smidt Direktør Vedhæftet fil Prospekt Kap. Blue Strait Capital 2023.03.28 FINAL clean
Kapitalforeningen Blue Strait Capital – Årsrapport 202228.3.2023 12:57:59 CEST | pressemeddelelse
København K, March 28, 2023 (GLOBE NEWSWIRE) -- Bestyrelsen har i dag behandlet og vedtaget årsrapporten 2022 for Kapitalforeningen Blue Strait Capital. Årsrapporten med beretning, regnskab og nøgletal er vedhæftet denne meddelelse og vil endvidere kunne downloades via hjemmesiden www.bluestraitcapital.dk. Årsrapporten vil blive fremlagt til godkendelse på foreningens ordinære generalforsamling den 25. april 2023. Spørgsmål til årsrapporten kan rettes til foreningens forvalter, BI Management A/S, Henrik Granlund på tlf. 77 30 90 00. Med venlig hilsen Kapitalforeningen Blue Strait Capital Kim Håkonsson, Bestyrelsesformand Merete Addis, Næstformand Vedhæftet fil 2022 Årsrapport Kapitalforeningen Blue Strait Capital FINAL